Concordance between upper and lower airway microbiota in infants with cystic fibrosis

European Respiratory Journal

Volumn 49, Issue 3, 2017, Pages

  Prevaes, Sabine M P J ^a   De Steenhuijsen Piters, Wouter A A ^a   De Winter De Groot, Karin M ^a   Janssens, Hettie M ^b   Tramper Stranders, Gerdien A ^a   Chu, Mei Ling J N ^a   Tiddens, Harm A ^b   Van Westreenen, Mireille ^c   Van Der Ent, Cornelis K ^a   Sanders, Elisabeth A M ^a   Bogaert, Debby ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^c ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL DNA; RNA 16S;

ACTINOMYCES; ARTICLE; BACTERIUM; CLINICAL ARTICLE; CONTROLLED STUDY; CORYNEBACTERIUM; DNA ISOLATION; DOLOSIGRANULUM; FEMALE; HAEMOPHILUS INFLUENZAE; HUMAN; INFANT; LACTOBACILLALES; LUNG FIBROSIS; LUNG LAVAGE; MALE; MICROBIAL COMMUNITY; MICROBIAL DIVERSITY; MORAXELLA; MOUTH FLORA; NASOPHARYNX; NEISSERIA; NONHUMAN; OBSERVATIONAL STUDY; OROPHARYNX; PORPHYROMONAS; PREVOTELLA; PREVOTELLA MELANINOGENICA; PRIORITY JOURNAL; PROSPECTIVE STUDY; RNA SEQUENCE; ROTHIA MUCILAGINOSA; SEQUENCE ALIGNMENT; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS; VEILLONELLA; VEILLONELLA DISPAR; BACTERIAL INFECTION; BRONCHOALVEOLAR LAVAGE FLUID; CLASSIFICATION; CLINICAL TRIAL; CYSTIC FIBROSIS; GENETICS; ISOLATION AND PURIFICATION; MICROBIOLOGY; MICROFLORA; MULTICENTER STUDY; NETHERLANDS; RESPIRATORY SYSTEM; RESPIRATORY TRACT INFECTION;

BACTERIA; BACTERIAL INFECTIONS; BRONCHOALVEOLAR LAVAGE FLUID; CYSTIC FIBROSIS; FEMALE; HUMANS; INFANT; MALE; MICROBIOTA; NETHERLANDS; PROSPECTIVE STUDIES; RESPIRATORY SYSTEM; RESPIRATORY TRACT INFECTIONS; RNA, RIBOSOMAL, 16S;

EID: 85032860630     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/13993003.02235-2016     Document Type: Article

References (46)

1. Coburn B, Wang PW, Diaz Caballero J, et al. Lung microbiota across age and disease stage in cystic fibrosis. Sci Rep 2015; 5: 10241.
2. Parkins MD, Floto RA. Emerging bacterial pathogens and changing concepts of bacterial pathogenesis in cystic fibrosis. J Cyst Fibros 2015; 14: 293–304.
3. Tracy M, Cogen J, Hoffman LR. The pediatric microbiome and the lung. Curr Opin Pediatr 2015; 7: 348–355.
4. Whiteson KL, Bailey B, Bergkessel M, et al. The upper respiratory tract as a microbial source for pulmonary infections in cystic fibrosis. Parallels from island biogeography. Am J Respir Crit Care Med 2014; 189: 1309–1315.
5. Marik PE. Aspiration pneumonitis and aspiration pneumonia. N Engl J Med 2001; 344: 665–671.
6. Morris A, Beck JM, Schloss PD, et al., Microbiome Project. Comparison of the respiratory microbiome in healthy nonsmokers and smokers. Am J Respir Crit Care Med 2013; 187: 1067–1075.
7. van der Gast CJ, Cuthbertson L, Rogers GB, et al. Three clinically distinct chronic pediatric airway infections share a common core microbiota. Ann Am Thorac Soc 2014; 11: 1039–1048.
8. Brennan S, Gangell C, Wainwright C, et al. Disease surveillance using bronchoalveolar lavage. Paediatr Respir Rev 2008; 9: 151–159.
9. Zampoli M, Pillay K, Carrara H, et al. Microbiological yield from induced sputum compared to oropharyngeal swab in young children with cystic fibrosis. J Cyst Fibros 2016; 15: 605–610.
10. Forton J. Induced sputum in young healthy children with cystic fibrosis. Paediatr Respir Rev 2015; 16: Suppl. 1, 6–8.
11. Mainz JG, Naehrlich L, Schien M, et al. Concordant genotype of upper and lower airways P. aeruginosa and S. aureus isolates in cystic fibrosis. Thorax 2009; 64: 535–540.
12. Taylor L, Corey M, Matlow A, et al. Comparison of throat swabs and nasopharyngeal suction specimens in non-sputum-producing patients with cystic fibrosis. Pediatr Pulmonol 2006; 41: 839–843.
13. Rosenfeld M, Emerson J, Accurso F, et al. Diagnostic accuracy of oropharyngeal cultures in infants and young children with cystic fibrosis. Pediatr Pulmonol 1999; 28: 321–328.
14. Doumit M, Belessis Y, Stelzer-Braid S, et al. Diagnostic accuracy and distress associated with oropharyngeal suction in cystic fibrosis. J Cyst Fibros 2016; 15: 473–478.
15. Armstrong DS, Grimwood K, Carlin JB, et al. Bronchoalveolar lavage or oropharyngeal cultures to identify lower respiratory pathogens in infants with cystic fibrosis. Pediatr Pulmonol 1996; 21: 267–275.
16. Renwick J, McNally P, John B, et al. The microbial community of the cystic fibrosis airway is disrupted in early life. PLoS One 2014; 9: e109798.
17. Boutin S, Graeber SY, Weitnauer M, et al. Comparison of microbiomes from different niches of upper and lower airways in children and adolescents with cystic fibrosis. PLoS One 2015; 10: e0116029.
18. Goddard AF, Staudinger BJ, Dowd SE, et al. Direct sampling of cystic fibrosis lungs indicates that DNA-based analyses of upper-airway specimens can misrepresent lung microbiota. Proc Natl Acad Sci USA 2012; 109: 13769–13774.
19. Prevaes SMPJ, de Winter-de Groot KM, Janssens HM, et al. Development of the nasopharyngeal microbiota in infants with cystic fibrosis. Am J Respir Crit Care Med 2016; 193: 504–515.
20. Satzke C, Turner P, Virolainen-Julkunen A, et al. Standard method for detecting upper respiratory carriage of Streptococcus pneumoniae: updated recommendations from the World Health Organization Pneumococcal Carriage Working Group. Vaccine 2013; 32: 165–179.
21. Matsen JM, Ederer GM. Specimen collection and transport. Hum Pathol 1976; 7: 297–307.
22. Linnane B, Clarke D, Murray P, et al. The benefit of taking a control sample when performing bronchoalveolar lavage. Thorax 2015; 70: 990.
23. de Blic J, Midulla F, Barbato A, et al. Bronchoalveolar lavage in children. ERS Task Force on bronchoalveolar lavage in children. European Respiratory Society. Eur Respir J 2000; 15: 217–231.
24. Wyllie AL, Chu MLJN, Schellens MHB, et al. Streptococcus pneumoniae in saliva of Dutch primary school children. PLoS One 2014; 9: e102045.
25. Bogaert D, Keijser B, Huse S, et al. Variability and diversity of nasopharyngeal microbiota in children: a metagenomic analysis. PLoS One 2011; 6: e17035.
26. Biesbroek G, Sanders EAM, Roeselers G, et al. Deep sequencing analyses of low density microbial communities: working at the boundary of accurate microbiota detection. PLoS One 2012; 7: e32942.
27. Caporaso JG, Kuczynski J, Stombaugh J, et al. QIIME allows analysis of high-throughput community sequencing data. Nat Meth 2010; 7: 335–336.
28. Hornef M. Pathogens, commensal symbionts, and pathobionts: discovery and functional effects on the host. ILAR J 2015; 56: 159–162.
29. de Steenhuijsen Piters WAA, Sanders EAM, Bogaert D. The role of the local microbial ecosystem in respiratory health and disease. Philos Trans R Soc Lond B Biol Sci 2015; 370: pii: 20140294.
30. Bosch AATM, Biesbroek G, Trzciński K, et al. Viral and bacterial interactions in the upper respiratory tract. PLoS Pathog 2013; 9: e1003057.
31. Biesbroek G, Bosch AATM, Wang X, et al. The impact of breastfeeding on nasopharyngeal microbial communities in infants. Am J Respir Crit Care Med 2014; 190: 298–308.
32. Magurran AE. Measuring Biological Diversity. Oxford, Blackwell Science, 2004.
33. Rogers GB, Shaw D, Marsh RL, et al. Respiratory microbiota: addressing clinical questions, informing clinical practice. Thorax 2015; 70: 74–81.
34. Letunic I, Bork P. Interactive Tree Of Life v2: online annotation and display of phylogenetic trees made easy. Nucleic Acids Res 2011; 39: W475–W478.
35. Oksanen J, Blanchet FG, Kindt R, et al. The R-project for statistical computing. Community ecology package “vegan”. 2015; version 2.3.0. https://cran.r-project.org/src/contrib/Archive/vegan/
36. Sly PD, Brennan S, Gangell C, et al., on behalf of the Australian Respiratory Early Surveillance Team for Cystic Fibrosis (AREST-CF). Lung disease at diagnosis in infants with cystic fibrosis detected by newborn screening. Am J Respir Crit Care Med 2009; 180: 146–152.
37. Sly PD, Gangell CL, Chen L, et al. Risk factors for bronchiectasis in children with cystic fibrosis. N Engl J Med 2013; 368: 1963–1970.
38. Zemanick ET, Wagner BD, Robertson CE, et al. Assessment of airway microbiota and inflammation in cystic fibrosis using multiple sampling methods. Ann Am Thorac Soc 2015; 12: 221–229.
39. Klepac-Ceraj V, Lemon KP, Martin TR, et al. Relationship between cystic fibrosis respiratory tract bacterial communities and age, genotype, antibiotics and Pseudomonas aeruginosa. Environ Microbiol 2010; 12: 1293–1303.
40. Cox MJ, Allgaier M, Taylor B, et al. Airway microbiota and pathogen abundance in age-stratified cystic fibrosis patients. PLoS One 2010; 5: e11044.
41. VanDevanter DR, LiPuma JJ. Microbial diversity in the cystic fibrosis airways: where is thy sting? Future Microbiol 2012; 7: 801–803.
42. Hampton TH, Green DM, Cutting GR, et al. The microbiome in pediatric cystic fibrosis patients: the role of shared environment suggests a window of intervention. Microbiome 2014; 2: 14.
43. Ramsey BW, Wentz KR, Smith AL, et al. Predictive value of oropharyngeal cultures for identifying lower airway bacteria in cystic fibrosis patients. Am Rev Respir Dis 1991; 144: 331–337.
44. Dickson RP, Erb-Downward JR, Freeman CM, et al. Spatial variation in the healthy human lung microbiome and the adapted island model of lung biogeography. Ann Am Thorac Soc 2015; 12: 821–830.
45. Charlson ES, Bittinger K, Haas AR, et al. Topographical continuity of bacterial populations in the healthy human respiratory tract. Am J Respir Crit Care Med 2011; 184: 957–963.
46. Hogan DA, Willger SD, Dolben EL, et al. Analysis of lung microbiota in bronchoalveolar lavage, protected brush and sputum samples from subjects with mild-to-moderate cystic fibrosis lung disease. PLoS One 2016; 11: e0149998.